NUPR1 dysregulation has been reported in several malignancies, including breast cancer [36], pancreatic cancer [11, 37], lung cancer [35], prostate cancer [38], colorectal cancer [39] and glioma [40]. This evidence concerns the gene NUPR1 and prostate carcinoma.